PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF CHLORZOXAZONE TABLET IN 10 HEALTHY VOLUNTEERS
Hongwei Zhang
Abstract
Hongwei Zhang
Abstract
A pharmacokinetics and relative bioavailability study of randomized cross-over design was carried out in ten healthy men who were given a single oral dose of chlorzoxazone in either of the two tablet formulations. Serum levels were determined by HPLC method. The concentration-time curve was fitted with a one compartment model. The pharma-cokinetic parameters of the detected tablet were as follows Cmax=12.30±3.74μg/ml, Tmax=1.13±0.23h, K=0.88±0.15h-1, T=0.81±0.14h, AUC0-8h=31.49±10.60μg·h/ml,In comparison with the standard tablet, the detected tablet is bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A pharmacokinetics and relative bioavailability study of randomized cross-over design was carried out in ten healthy men who were given a single oral dose of chlorzoxazone in either of the two tablet formulations. Serum levels were determined by HPLC method. The concentration-time curve was fitted with a one compartment model. The pharma-cokinetic parameters of the detected tablet were as follows Cmax=12.30±3.74μg/ml, Tmax=1.13±0.23h, K=0.88±0.15h-1, T=0.81±0.14h, AUC0-8h=31.49±10.60μg·h/ml,In comparison with the standard tablet, the detected tablet is bioequivalent.
Key concepts: Bioequivalence, Chlorzoxazone, Bioavailability, Cmax, Pharmacokinetics, Pharmacology, Chromatography, Chemistry